Reuters logo
7 days ago
BRIEF-Kalvista Pharmaceuticals enters into an at-market sales agreement with BTIG
July 13, 2017 / 9:59 PM / 7 days ago

BRIEF-Kalvista Pharmaceuticals enters into an at-market sales agreement with BTIG

1 Min Read

July 13 (Reuters) - Kalvista Pharmaceuticals Inc

* Kalvista Pharmaceuticals Inc - on July 13, 2017 co entered into an at--market sales agreement with BTIG, LLC

* Kalvista Pharmaceuticals - Kalvista may offer, sell, from time to time through BTIG, shares of its common stock, par value $0.001 per share - SEC filing Source: (bit.ly/2uXlNgG) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below